Invention Application
US20150011470A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS
审中-公开
N1-PYRAZOLOSPIROKETONE乙酰辅酶A羧酸酶抑制剂
- Patent Title: N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS
- Patent Title (中): N1-PYRAZOLOSPIROKETONE乙酰辅酶A羧酸酶抑制剂
-
Application No.: US14491016Application Date: 2014-09-19
-
Publication No.: US20150011470A1Publication Date: 2015-01-08
- Inventor: Mary Theresa Didiuk , Robert Lee Dow , David Andrew Griffith
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: PFIZER INC.
- Current Assignee: PFIZER INC.
- Current Assignee Address: US NY New York
- Main IPC: C07D471/10
- IPC: C07D471/10 ; A61K45/06 ; A61K31/519 ; A61K31/435
Abstract:
The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3, Z, A1, L and A2 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
Public/Granted literature
- US09145416B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors Public/Granted day:2015-09-29
Information query
